Pneumococcal Vaccines: Current Status and Future Prospects

Dear Colleagues,

Streptococcus pneumonia, also known as Pneumococcus, is responsible for causing significant morbidity and mortality worldwide, especially among the very young and the elderly. Pneumococcal vaccines have effectively reduced the incidence of pneumococcal disease, particularly in these high-risk populations. However, maintaining high levels of protection against pneumococcal infections worldwide is challenging. The effectiveness of currently available vaccines is affected by multiple factors such as pneumococcal serotype replacement, vaccine formulation and vaccination schedule used in each setting, vaccination coverage, and prevalence of comorbidities.

In this Special Issue of Vaccines, we aim to gather an important collection of articles that explore the latest research and development efforts in pneumococcal vaccines. We welcome Original Articles, Literature Reviews, and Viewpoints covering vaccination programs, the epidemiology of pneumococcal disease, and the challenges and opportunities for further vaccine development.

Dr. Vana Spoulou
Dr. Joanna Papadatou
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• streptococcus pneumonia
• pneumococcal disease
• pneumococcal vaccines
• epidemiology